|
楼主 |
发表于 2022-4-7 22:46:42
|
显示全部楼层
The Fv containing the two variable domains (VH+VL) of immunoglobulins and engineered fragments thereof (e.g. single chain Fv (scFv) [1] or the disulphide stabilised Fv (dsFv) [2]) have been considered as the smallest antibody fragments with retention of the full antigen binding capacity [3,4]. PCR and the development of powerful panning techniques led to the generation of large libraries of scFvs from which several binders could be selected successfully [5-7]. This strategy to obtain binders for a large number of antigens was a major breakthrough in molecular biology. However, the application of the technique is not straightforward [3]. The cloning of two correctly spliced gene fragments (VH+VL) is a difficult step, generating a representative library is tedious, and the genetic constructs are often unstable in the bacterial host. Also, the expression yield, stability and/or functionality of scFv or dsFv often turn out to be problematic [8]. The work of Ward et al. [9] indicated that binders could be readily selected from a pool of cloned spleen VHs from an immunised mouse. These isolated VH domains are expected to bind antigen in absence of VLs. This approach avoids the introduction of a peptide linker used in the scFv constructs which might create additional problems (e.g. reduced affinity, aggregation or proteolytic cleavage) [10]. However, the insolubility of the isolated VH domains expressed in bacteria, and their reduced antigen binding affinity relative to the original VH-VL combination, posed serious limitations for their use. Reshaping the 'VL side' of the human VH to mimic the variable domain of camel heavy-chain immunoglobulins solved the solubility problem [11]. The camelisation of the human VH was based on the knowledge that Camelidae produce a substantial proportion of their functional immunoglobulins as homodimers of heavy chains, lacking light chains [12]. The variable domains of these heavy-chain antibodies are distinguishable from the classical VH domains because they consistently carry important substitutions of otherwise conserved amino acids located in the region which is normally covered by the VL [13,14]. To distinguish the classical VH domain from the variable domains of the camel heavy-chain antibodies we refer to the latter as VHH.
|
|